Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure

Blood - Tập 119 - Trang 3403-3412 - 2012
H. Jean Khoury1, Jorge E. Cortes2, Hagop M. Kantarjian2, Carlo Gambacorti-Passerini3, Michele Baccarani4, Dong-Wook Kim5, Andrey Zaritskey6,7, Athena Countouriotis8, Nadine Besson9, Eric Leip10, Virginia Kelly10, Tim H. Brümmendorf11,12
1Winship Cancer Institute of Emory University, Atlanta, GA
2University of Texas MD Anderson Cancer Center, Houston, TX
3University Milan Bicocca, Monza, Italy
4University of Bologna, Bologna, Italy
5Seoul St. Mary’s Hospital, Seoul, South Korea
6University of Pavlov, St Petersburg, Russia
7Almazov Federal Heart, Blood and Endocrinology Centre, St Petersburg, Russia
8Pfizer Inc, La Jolla, CA;
9Pfizer Global Research and Development, Paris, France
10Pfizer Inc., Cambridge, MA
11Universitäts-Klinikum Aachen, RWTH Aachen, Germany;
12Universitäts-Klinikum Hamburg-Eppendorf, Hamburg, Germany;

Thông tin
Thông tin xuất bản

Blood

Tập 119

3403-3412

Thông tin tác giả